Laser scleral microporation may solve biomechanical problem of presbyopia
CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Alex Lopez of Ace Vision Group discusses laser scleral microporation for presbyopia.
Lopez said the GenII device can potentially deliver improved near vision without compromising distance vision in patients with presbyopia. The company plans to do a study in the United States in 2026, potentially leading to commercial availability in the U.S. in 2027.
“Presbyopia is a biomechanical problem with refractive consequences,” he said. “We finally have a solution that can potentially restore biomechanical movement and help patients regain that near vision they want in a natural way.”
Explore More Articles
Ace Vision Group Names Rob Kissling, MD, as Chief Medical Officer
Ace Vision Group announced that it has named Rob Kissling, MD, as Chief Medical Officer. Dr. Kissling has more than 20 years of experience integrating clinical development, medical strategy, and business planning to develop and commercialize devices and medicines for ophthalmology. His tenure has included companies such as Pharmacia, Pfizer, and Novartis. Most recently, he …
read moreARVO LIVE: AI revolution in ophthalmology
Ophthalmology Times® talked with AnnMarie Hipsley, DPT, PhD, about 3D finite element model used to understand more about the biomechanics of accommodation and dis-accommodation as it relates to functions for visual function as well as aqueous hydrodynamics at this year’s ARVO meeting.
read moreIs presbyopia the newest specialty?
The presbyopia landscape is crowded today with innovations to treat this condition, including corneal procedures, pharmacologic treatments, scleral procedures, and phakic and intraocular (IOL) lenses, according to Karolinne Maia Rocha, MD, PhD, director of cornea and refractive surgery at the Medical University of South Carolina in Charleston. Corneal proceduresProcedures that are coming down the pike …
read more